Delivery Order SPE2DR25D2009-SPE2DR26FJ5K9
- Not listed
- The Defense Logistics Agency awarded a $49,795.38 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors on January 13, 2026, with an ultimate completion date of January 14, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen is a subsidiary of parent company Cencora, Inc., a major...
- The Defense Logistics Agency awarded a $16,434.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors on January 16, 2026, with an ultimate completion date of January 20, 2026. The contract, which involves no set-aside designation, was executed competitively and represents a direct supply of this specialty pharmaceutical product to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $2,436.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injectors on January 15, 2026, with completion scheduled for January 16, 2026. This non-set-aside award is being fulfilled at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc., serves as a critical supplier to federal medical procurement, particularly for...
- The Defense Logistics Agency awarded a $41,759.43 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is the vendor's...
- The Defense Logistics Agency awarded a $18,521.79 firm fixed-price delivery order to AmerisourceBergen Drug Corp (Conshohocken, PA) on January 13, 2026, for the supply of REPATHA 140 mg/ml SureClick auto-injectors, with completion scheduled for January 14, 2026. This non-competitive delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. The award is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,955.33 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. This competitive award, issued on December 11, 2025, with an ultimate completion date of December 12, 2025, represents a firm fixed-price transaction with no set-aside designation. The drug will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $8,232.28 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of August 13, 2025. This competitive, firm fixed-price delivery order represents a continuation of pharmaceutical supply under AmerisourceBergen's existing contract vehicle with DLA. The award carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $14,120.29 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military...
- The Defense Logistics Agency awarded a delivery order valued at $55,027.37 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of August 21, 2025. This firm fixed-price contract, awarded on August 20, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,859.55 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of April 23, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical vendor that...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ5K9Delivery Order
The Defense Logistics Agency awarded a $21,336.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of January 21, 2026. This non-set-aside competitive award was issued on January 20, 2026, and will be fulfilled from the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal military and healthcare systems through multiple contract vehicles with DLA. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at up to $999,999,999 through December 2026. This comprehensive IDC enables the company to supply a vast range of pharmaceutical products and medical supplies globally to support military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. REPATHA, a cardiovascular medication used for cholesterol management, represents the type of critical pharmaceutical commodity delivered under this prime vendor agreement to military treatment facilities and defense healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.3k | 1/19/26 |